However, our result is contrary to that of Li et al. [41], who concluded that TERT rs2853669 polymorphisms were associated with the increased risk of developing breast cancer (OR = 0.76; 95% CI: 0.63–0.90; P = 0.002). Here, TERT is linked to breast cancer.